US Pharma Spend Analysis (FDA Medicare)
$48Bn+ in US Medicare drug spend with no structured view of which categories, manufacturers, or brands were driving it.
- Accomplished end-to-end pharma market analysis by querying 100,000+ FDA Medicare records across 1,200+ brands using Python and 6 advanced SQL queries (CTEs, LAG, window functions), which resulted in identifying oncology and immunology as the top spend categories within $48Bn+ in annual US drug expenditure.
- Accomplished manufacturer concentration risk mapping by building a 6-chart Power BI dashboard and 3-slide consulting deck, which resulted in a simulation-format deliverable replicating real pharma advisory output.
